- | Pays :
- France
- Italy
- Austria
- Les 3 autres...
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of the study is to assess the safety of IV administration of rIX-FP. Safety will be evaluated by adverse events and laboratory changes over time. The secondary objective of the study is to evaluate the pharmacokinetics parameters, following a single intravenous dose of rIX-FP.
Critère d'inclusion
- Hemophilia B